Effect of mibefradil on heart rate variability in patients with chronic heart failure

This publication has 17 references indexed in Scilit:

• The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
  Published by Elsevier ,2010
• Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure
  Circulation, 1998
• Current medical therapy for advanced heart failure
  American Heart Journal, 1998
• The design of the mortality assessment in congestive heart failure trial (MACH-1, Mibefradil)
  Clinical Cardiology, 1997
• Prognostic Value of Heart Rate Variability in Chronic Congestive Heart Failure Secondary to Idiopathic or Ischemic Dilated Cardiomyopathy
  The American Journal of Cardiology, 1997
• Evaluating the safety of mibefradil, a selective T-type calcium antagonist, in patients with chronic congestive heart failure
  Clinical Therapeutics, 1996
• Heart Rate Variability
  Circulation, 1996
• Effects of the new calcium antagonist mibefradil (Ro 40-5967) on exercise duration in patients with chronic stable angina pectoris: A multicenter, placebo-controlled study
  American Heart Journal, 1995
• Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment.
  Heart, 1994
• Selective inhibition of T-type Ca2+ channels by Ro 40-5967.
  Circulation Research, 1994